Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes

N-(benzothiazol-2-yl)benzenesulphonamide (BS2ABT) was synthesized by the condensation (by refluxing) of 2-aminobenzothiazole and benzenesulphonylchloride in acetone at 140ºC. The resulting crude precipitates were recrystallized from dimethylformamide (DMF). Five metal complexes of copper(I), nickel(...

Full description

Saved in:
Bibliographic Details
Main Authors: N. L. Obasi, Okoye C. O. Benedict, P. O. Ukoha, A. O. Anaga
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:E-Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2012/496541
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553422669217792
author N. L. Obasi
Okoye C. O. Benedict
P. O. Ukoha
A. O. Anaga
author_facet N. L. Obasi
Okoye C. O. Benedict
P. O. Ukoha
A. O. Anaga
author_sort N. L. Obasi
collection DOAJ
description N-(benzothiazol-2-yl)benzenesulphonamide (BS2ABT) was synthesized by the condensation (by refluxing) of 2-aminobenzothiazole and benzenesulphonylchloride in acetone at 140ºC. The resulting crude precipitates were recrystallized from dimethylformamide (DMF). Five metal complexes of copper(I), nickel(II), manganese(II), cobalt(II) and zinc(II) of the ligands were synthesized. The compounds were characterized using magnetic susceptibility measurements, UV/VIS spectrophotometry, infra red, proton and 13C nmr spectroscopies. The antimicrobial tests of the ligands and its metal complexes were carried out on both multi-resistant bacterial strains isolated under clinical conditions and cultured species using agar-well diffusion method. The multi-resistant bacterial strains used were Escherichia coli, Proteus species, Pseudomonas aeroginosa and Staphylococcus aureus which were isolated from dogs. The culture species were Pseudomonas aeruginosa (ATCC 27853), Escherichia Coli (ATCC 25922) Staphylococcus aureus (ATCC 25923), and the fungi, Candida krusei (ATCC 6258) and Candida albicans (ATCC 90028). The tests were both in vitro and in vivo. Thus the Inhibition Zone Diameter (IZD), the Minimum Inhibitory Concentration (MIC), and the Lethal and Effective Concentrations (LC50 and EC50) were determined. The antimicrobial activities of the compounds were compared with those of Ciprofloxacin and trimethoprim-sulphamethoxazole as antibacterial agents and Fluconazole as an antifungal drug. All the compounds showed varying activities against the cultured typed bacteria and fungi used. However, they were less active than the standard drugs used except Fluconazole which did not show any activity against Candida krusei (ATCC 6258) but most of the compounds synthesized were very active against it. The Lethal Concentration (LC50) ranged from 26.25±4.9-1833.88±186.92 ppm. These are within the permissible concentrations.
format Article
id doaj-art-c366f49b5ee54dc48a49119d34da7fb3
institution Kabale University
issn 0973-4945
2090-9810
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series E-Journal of Chemistry
spelling doaj-art-c366f49b5ee54dc48a49119d34da7fb32025-02-03T05:53:59ZengWileyE-Journal of Chemistry0973-49452090-98102012-01-01942354237010.1155/2012/496541Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) ComplexesN. L. Obasi0Okoye C. O. Benedict1P. O. Ukoha2A. O. Anaga3Department of Pure and Industrial Chemistry, University of Nigeria, Nsukka, Enugu State, NigeriaDepartment of Pure and Industrial Chemistry, University of Nigeria, Nsukka, Enugu State, NigeriaDepartment of Pure and Industrial Chemistry, University of Nigeria, Nsukka, Enugu State, NigeriaDepartment of Physiology and Pharmacology, University of Nigeria, Nsukka, NigeriaN-(benzothiazol-2-yl)benzenesulphonamide (BS2ABT) was synthesized by the condensation (by refluxing) of 2-aminobenzothiazole and benzenesulphonylchloride in acetone at 140ºC. The resulting crude precipitates were recrystallized from dimethylformamide (DMF). Five metal complexes of copper(I), nickel(II), manganese(II), cobalt(II) and zinc(II) of the ligands were synthesized. The compounds were characterized using magnetic susceptibility measurements, UV/VIS spectrophotometry, infra red, proton and 13C nmr spectroscopies. The antimicrobial tests of the ligands and its metal complexes were carried out on both multi-resistant bacterial strains isolated under clinical conditions and cultured species using agar-well diffusion method. The multi-resistant bacterial strains used were Escherichia coli, Proteus species, Pseudomonas aeroginosa and Staphylococcus aureus which were isolated from dogs. The culture species were Pseudomonas aeruginosa (ATCC 27853), Escherichia Coli (ATCC 25922) Staphylococcus aureus (ATCC 25923), and the fungi, Candida krusei (ATCC 6258) and Candida albicans (ATCC 90028). The tests were both in vitro and in vivo. Thus the Inhibition Zone Diameter (IZD), the Minimum Inhibitory Concentration (MIC), and the Lethal and Effective Concentrations (LC50 and EC50) were determined. The antimicrobial activities of the compounds were compared with those of Ciprofloxacin and trimethoprim-sulphamethoxazole as antibacterial agents and Fluconazole as an antifungal drug. All the compounds showed varying activities against the cultured typed bacteria and fungi used. However, they were less active than the standard drugs used except Fluconazole which did not show any activity against Candida krusei (ATCC 6258) but most of the compounds synthesized were very active against it. The Lethal Concentration (LC50) ranged from 26.25±4.9-1833.88±186.92 ppm. These are within the permissible concentrations.http://dx.doi.org/10.1155/2012/496541
spellingShingle N. L. Obasi
Okoye C. O. Benedict
P. O. Ukoha
A. O. Anaga
Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes
E-Journal of Chemistry
title Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes
title_full Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes
title_fullStr Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes
title_full_unstemmed Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes
title_short Syntheses, Characterization, and Antimicrobial Screening of N-(benzothiazol-2-yl)benzenesulphonamide and its Cu(I), Ni(II), Mn(II), Co(II), and Zn(II) Complexes
title_sort syntheses characterization and antimicrobial screening of n benzothiazol 2 yl benzenesulphonamide and its cu i ni ii mn ii co ii and zn ii complexes
url http://dx.doi.org/10.1155/2012/496541
work_keys_str_mv AT nlobasi synthesescharacterizationandantimicrobialscreeningofnbenzothiazol2ylbenzenesulphonamideanditscuiniiimniicoiiandzniicomplexes
AT okoyecobenedict synthesescharacterizationandantimicrobialscreeningofnbenzothiazol2ylbenzenesulphonamideanditscuiniiimniicoiiandzniicomplexes
AT poukoha synthesescharacterizationandantimicrobialscreeningofnbenzothiazol2ylbenzenesulphonamideanditscuiniiimniicoiiandzniicomplexes
AT aoanaga synthesescharacterizationandantimicrobialscreeningofnbenzothiazol2ylbenzenesulphonamideanditscuiniiimniicoiiandzniicomplexes